Repetitive prostatic massage and drug therapy as an alternative to transurethral resection of the prostate.
We describe 5 men with urinary retention and indwelling urethral catheters who were treated with repetitive prostatic massage, antimicrobials, alpha blockers, and--in 2 cases--finasteride. We retrospectively reviewed the charts of all patients presenting to the genitourinary clinic with indwelling urinary catheters during a 1-year period. Five men (mean age, 70 years; range, 64-76; SD 4.47) presented to the Manila Genitourinary Clinic (Cebu Branch), Cebu, Philippines, wearing indwelling urinary catheters placed for acute urinary retention. Urologists had told all 5 men that they needed to undergo transurethral resection of the prostate (TURP). The Cebu genitourinary physician removed the catheters, instituted repetitive prostatic massage, and diagnosed all 5 patients with prostatitis. All 5 patients received repetitive prostatic massage, alpha-blocker medication, and antibiotic therapy, whereas finasteride was given to 2 patients. During treatment, statistically significant improvements occurred in global symptom severity scores, urethral white blood cell (WBC) counts, WBC counts of the expressed prostatic secretions (EPS), EPS red blood cell (RBC) counts, urinary WBC counts, and urinary RBC counts. Fluorescing Chlamydia elementary bodies disappeared in 3 of the 4 positive patients by the end of treatment. (One patient was not available for retesting.) Repetitive prostatic massage, antimicrobial therapy, alpha-blocker therapy, and--in 2 cases--finasteride enabled catheter removal in all 5 men (100%) as well as successful urination in all 5 men (100%). TURP has been prevented for a mean of 2.53 years (range, 16-38 months).
Hennenfent
Bradley R
BR
Prostatitis Foundation, Smithshire, Illinois, USA.
Lazarte
Alfred R
AR
Feliciano
Antonio E
AE
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000529:Complementary Therapies / Q000639:trends*; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008405:Massage / Q000379:methods*; D008875:Middle Aged; D011467:Prostate / Q000187:drug effects / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000628:therapy; D011472:Prostatitis / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D012189:Retrospective Studies; D020728:Transurethral Resection of Prostate; D014546:Urinary Catheterization; D016055:Urinary Retention / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*
D000317:Adrenergic alpha-Antagonists; D000890:Anti-Infective Agents; D018120:Finasteride